Skip to content

Screening of early gastric cancer in health examination populations

Screening of early gastric cancer in health examination populations

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000034789
Enrollment
Unknown
Registered
2020-07-19
Start date
2020-08-01
Completion date
Unknown
Last updated
2020-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cancer

Interventions

medium risk:Draw venous blood, gastroscopy
high risk:Draw venous blood, gastroscopy

Sponsors

Songjiang Hospital Affiliated to Shanghai Jiaotong University School of Medicine (Preparatory Stage)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 79 Years

Inclusion criteria

Inclusion criteria: 1. Patients with moderate risk and high risk; 2. Age: male 40-79 years old, female 50-79 years old.

Exclusion criteria

Exclusion criteria: 1. Patients within one year after the last gastroscopy examination; 2. Patients with history of subtotal gastrectomy; 3. Patients taking PPI within two weeks (omeprazole, esomeprazole, pantoprazole, rabeprazole, lansoprazole, etc.) or H2 receptor antagonists (famotidine, etc.); 4. Patients with one or more of the following symptoms: (1) Iron deficiency anemia within 6 months (2) Gastrointestinal bleeding (black stool, bloody stool, etc.) within 12 months; (3) Weight loss (weight loss >=4.5kg in 6 months without weight loss reasons); (4) Recurrent diarrhea; (5) Difficulty swallowing or choking; (6) Abdominal mass; 5. Patients with a history of any of the following diseases: esophageal cancer, gastric cancer, colorectal cancer, polyposis, inflammatory bowel disease, and malignant tumors of other organs; 6. Patients who are highly suspected of cancer by imaging and tumor markers; 7. Patients with severe heart, lung, liver and kidney dysfunction or severe mental disorders.

Design outcomes

Primary

MeasureTime frame
detection rate of early gastric cancer;

Countries

China

Contacts

Public ContactXu Ping

Songjiang Hospital Affiliated to Shanghai Jiaotong University School of Medicine (Preparatory Stage)

sjzxxp@yeah.net+86 21-67722251

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026